GOED shares insights on EPA/DHA finished product market and omega-3’s connection to ADHD

Published: 9-May-2024
Training & Education Ingredients

The reports detail the trends the EPA and DHA markets are experiencing, as well as omega-3's impact on people with ADHD

The Global Organisation for EPA and DHA Omega-3s (GOED) recently published two reports on the EPA and DHA omega-3 industry: a biennial report on the global finished products market for EPA and DHA omega-3s and a scientific report on Attention Deficit Hyperactivity Disorder (ADHD) and omega-3s.

 

EPA and DHA finished products: a market insight

The 2024 Finished Product Report offers a comprehensive overview of six key markets: dietary supplements, pharmaceuticals, food and beverage, pet nutrition, infant formula and clinical nutrition/medical foods. 

Together, these categories reached USD $52.4bn in sales in 2023, primarily influenced by inflation and higher prices.

Some key takeaways from the report:

  • The pet nutrition segment exhibited strong growth of 8.8% annually, reaching $1.5 billion in sales in 2023
  • The supplement category also grew, but the dollar increase was driven primarily by increased prices as a result of fish oil shortages
  • The DHA-fortified infant nutrition market is by far the largest of the consumer product categories, although birth rates across the globe are on the decline, resulting in a growth of 2.9% in 2023
  • Looking ahead, sales of EPA and DHA finished products are poised to increase an average of 3.3% annually through 2025.

The report encompasses market statistics and trend analyses across 11 regions for 2022 and 2023, with forecasts extending through 2025.

 

Omega-3 and ADHD

The second report, EPA and DHA Supplementation and Attention Deficit Hyperactivity Disorder, explores the latest research on the impact of EPA+DHA omega-3 supplementation on ADHD and associated ADHD outcomes. 

The report was created using GOED’s Clinical Study Database (CSD), a powerful tool that catalogs all human clinical studies on EPA and DHA omega-3s.

EPA+DHA have been suggested to play a potential role in reducing the symptoms associated with ADHD and the report analyses the studies conducted on people who have been diagnosed with ADHD, or people who have been assessed using ADHD criteria for symptoms. 

The report also provides key takeaways and suggests next steps for research.

  • Companies:
  • GOED
See more

You may also like

Ingredients

GOED debuts its 2024 omega-3 market report

Read more
The report details the current movements in the omega-3 market, as well as making forecasts for the next couple of years

Trending Articles

  1. dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on gut health and overall wellness
  2. Tate & Lyle debuts mouthfeel trend report for better food and beverage formulation The company highlights the top nine most popular trends in food and beverage formulation, including hyper-crunch, mouthfeel mimicry and climate-proof food
  3. Alland & Robert continues to lead the way with gum acacia solutions that contribute to a healthier and more sustainable future As the global leader and pioneer of natural gums, Alland & Robert is focused on creating ingredients for a healthier tomorrow and providing tailor-made support for innovation projects
  4. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  5. Burcon and Puratos join forces to develop canola protein-based egg alternative The two companies are aiming to develop Burcon's plant-based canola protein, Puratein, as an egg replacement solution in functional food bakery and patisserie products

Upcoming event

Vitafoods India

5–7 February 2025 | Exhibition | Mumbai See all

You may also like

Ingredients

GOED debuts its 2024 omega-3 market report

The report details the current movements in the omega-3 market, as well as making forecasts for the next couple of years
Training & Education

GOED’s launches programme to acknowledge high accuracy in quantifying EPA and DHA in omega-3 oils

The organisation's Special Achievement Programme will acknowledge laboratories that accurately quantify EPA and DHA levels in omega-3 ingredients and supplements
Training & Education

GOED publishes omega-3 diagnostics testing

The review highlights the landscape of available omega-3 tests and the evidence linking LCPUFA intake to improved health
Ingredients

GOED releases two market research reports: annual global omega-3 ingredient market and consumer search trends

The Global Organization for EPA and DHA Omega-3s (GOED) has published two important reports detailing trends in the global EPA and DHA omega-3 industry
Ingredients

GOED releases sustainability report for the EPA and DHA Omega-3 Industry

Following the UN's publication of its Sustainable Development Goals, GOED's sustainability report goes some way to providing a response to the growing pressure on companies
Ingredients

GOED provides insights into EPA and DHA omega-3s and skin health through two new reports

The reports were created with the help of GOED’s Clinical Study Database (CSD), a powerful tool GOED developed to organise all human clinical studies
Ingredients

GOED publishes brain health report

The report was created with the help of GOED’s Clinical Study Database (CSD), a powerful tool developed and maintained by GOED
Subscribe now